Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available
News
No Recent News for the Company
Announcements 
Closure of Trading Window
31-Mar-2026 | Source : BSEWe hereby submit the Intimation of Closure of Trading Window for insiders of the Company.
Listing of Equity Shares of Speciality Medicines Ltd
30-Mar-2026 | Source : BSETrading Members of the Exchange are hereby informed that effective from March 30 2026 the Equity Shares of Speciality Medicines Ltd (Scrip Code: 544738) are listed and admitted to dealings on the Exchange in the list of MT Group Securities. For further details please refer to the notice no. 20260327- dated March 27 2026.
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
6.96
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.24%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
31
Price to Book Value
3.66
EV to EBIT
12.86
EV to EBITDA
12.58
EV to Capital Employed
3.43
EV to Sales
1.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
26.64%
ROE (Latest)
28.31%
Technicals key factors
Indicator
Weekly
Monthly
Technical indicator has not been calculated since the stock has been active for a short period
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.